Prestige Consumer Healthcare (PBH) Asset Utilization Ratio (2011 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Asset Utilization Ratio came in at 0.32 in Q4 2025, down 5.44% year-on-year from 0.34 in Q4 2024, and down 1.52% quarter-over-quarter from 0.32 in Q3 2025.
Prestige Consumer Healthcare (PBH) Asset Utilization Ratio (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Asset Utilization Ratio history runs 15 years deep, the most recent figure standing at 0.32 for Q4 2025.
- On a quarterly basis, Asset Utilization Ratio fell 5.44% year-over-year to 0.32 in Q4 2025; TTM through Dec 2025 was 0.32, a 5.44% decrease from a year earlier, with the FY2025 full-year figure at 0.34, changed 0.37% from the prior year.
- Asset Utilization Ratio fell to 0.32 in Q4 2025 per PBH's latest filing, from 0.32 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.34 in Q4 2023 and bottomed at 0.27 in Q1 2021.
- The 5-year median for Asset Utilization Ratio is 0.32 (2025), against an average of 0.32.
- Across the five-year window, Asset Utilization Ratio gained 13.88% in 2023 and decreased 5.44% in 2025, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.29 in 2021, then grew by 3.52% to 0.3 in 2022, then increased by 13.88% to 0.34 in 2023, then dropped by 1.02% to 0.34 in 2024, then fell by 5.44% to 0.32 in 2025.
- Per Business Quant, the three latest PBH Asset Utilization Ratio figures stand at 0.32 (Q4 2025), 0.32 (Q3 2025), and 0.33 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.43 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.62 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.46 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.43 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.65 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.37 |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 0.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.32 |
| Sep 30, 2025 | 0.32 |
| Jun 30, 2025 | 0.33 |
| Mar 31, 2025 | 0.34 |
| Dec 31, 2024 | 0.34 |
| Sep 30, 2024 | 0.34 |
| Jun 30, 2024 | 0.34 |
| Mar 31, 2024 | 0.34 |
| Dec 31, 2023 | 0.34 |
| Sep 30, 2023 | 0.34 |
| Jun 30, 2023 | 0.34 |
| Mar 31, 2023 | 0.32 |
| Dec 31, 2022 | 0.30 |
| Sep 30, 2022 | 0.30 |
| Jun 30, 2022 | 0.30 |
| Mar 31, 2022 | 0.30 |
| Dec 31, 2021 | 0.29 |
| Sep 30, 2021 | 0.28 |
| Jun 30, 2021 | 0.28 |
| Mar 31, 2021 | 0.27 |